medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2018, Number 3

<< Back Next >>

Acta Med 2018; 16 (3)

Therapeutic adherence: a health care problem

Ortega CJJ, Sánchez HD, Rodríguez MÓA, Ortega LJM

Language: Spanish
References: 38
Page: 226-232
PDF size: 257.43 Kb.


ABSTRACT

It is widely known that the lack of adherence to treatment is the main cause of not obtaining all the benefits that medicines can provide to patients, and yet, in daily clinical practice, we continue not to integrate this fact as the first cause of therapeutic failure, often resorting to the intensification of treatments or unnecessary tests that can put the patient at risk. The lack of therapeutic adherence is a problem of great impact worldwide, predominating mainly in patients with chronic diseases, in which long term adherence is little more than 50%, and even lower in developing countries. As a consequence, there are higher rates of hospitalization, increased health costs and therapeutic failures, among others. According to the World Health Organization (WHO), there are five factors involved in adherence: socioeconomic, treatment-related, patient-related, disease-related and health equipment-related. Although several plans have been described to improve adherence, with the evidence available so far, a specific strategies that is effective and useful in all cases can’t be recommended at this time.


REFERENCES

  1. Arévalo AM, López GM, López SD, Martínez RF. Adherencia a la terapéutica farmacológica en pacientes con hipertensión arterial. Revista Médica HJCA. 2016; 8 (1): 8-13.

  2. Sánchez N. Adherencia terapéutica en hipertensión arterial sistémica. Rev Mex Enf Cardiol. 2006; 14 (3): 98-101.

  3. Seabury SA, Gupta CN, Philipson TJ, Henkhaus LE; PhRMA Medication Adherence Advisory Council. Understanding and overcoming barriers to medication adherence: a review of research priorities. J Manag Care Pharm. 2014; 20 (8): 775-783.

  4. Salinas E, Nava M. Adherencia terapéutica. Enf Neurol (Mex). 2012; 11 (2): 102-104.

  5. Cutler DM, Everett W. Thinking outside the pillbox-medication adherence as a priority for health care reform. N Engl J Med. 2010; 362 (17): 1553-1555.

  6. Holguín PL, Correa D, Arrivillaga M, Cáceres D, Varela M. Adherencia al tratamiento de hipertensión arterial: efectividad de un programa de intervención biopsicosocial. Univ Psychol Bogotá (Colombia). 2006; 5 (3): 535-547.

  7. Rodríguez MA, Pérez EM, García JE, Rodríguez CA, Martínez MF, Faus DM. Revisión de estrategias utilizadas para la mejora de la adherencia al tratamiento farmacológico. Pharm Care Eso. 2014; 16(3): 110-120.

  8. Goldman L, AM Epstein. Improving adherence-money isn’t the only thing. N Engl J Med. 2011; 365: 2131-2133.

  9. Mistry N, Keepanasseril A, Wilczynski NL, Nieuwlaat R, Ravall M, Haynes RB et al. Technology-mediated interventions for enhancing medication adherence. Oxford University Press. J Am Med Inform Assoc 2015; 22 (e1): e177-193.

  10. Serrano PJ, Pozo C, Alonso ME, Martos MJ, Bretones NB. Factores vinculados a la adhesión al tratamiento
en pacientes con epilepsia refractaria y no refractaria. Rev Neurol. 2011; 53 (12): 721-728.

  11. Ruilope LM, Chagas AC, Brandăo AA, Gómez-Berroterán R, Alcalá JJ, Paris JV et al. Hypertension in Latin America: current perspectives on trends and characteristics. Hipertens Riesgo Vasc. 2017; 34 (1): 50-56.

  12. Hutchins DS, Zeber JE, Roberts CS, Williams AF, Manias E, Peterson AM et al. Initial medication adherence-review and recommendations for good practices in outcomes research: an ISPOR medication adherence and persistence special interest group report. Value Health. 2015; 18 (5): 690-699.

  13. Carhuallanqui R, Diestra CG, Tang HJ, Málaga G. Adherencia al tratamiento farmacológico en pacientes hipertensos atendidos en un hospital general. Rev Med Hered. 2010; 21 (4): 197-201.

  14. Han E, Suh DC, Lee SM, Jang S. The impact of medication adherence on health outcomes for chronic metabolic diseases: A retrospective cohort study. Res Social Adm Pharm. 2014; 10 (6): e87-98.

  15. Dilla T, Valladares A, Lizán L, Sacristána JA. Adherencia y persistencia terapéutica: causas, consecuencias y estrategias de mejora. Aten Primaria. 2009; 41 (6): 342-348.

  16. Gosmanova EO, Kovesdy CP. Adherence to antihypertensive medications: is prescribing the right pill enough? Nephrol Dial Transplant. 2015; 30 (10): 1649-1656.

  17. Rosenbaum L, Shrank WH. Taking our medicine-improving adherence in the accountability era. N Engl J Med. 2013; 369 (8): 694-695.

  18. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005; (4): CD000011.

  19. Hedegaard U, Kjeldsen LJ, Pottegĺrd A, Henriksen JE, Lambrechtsen J, Hangaard J et al. Improving medication adherence in patients with hypertension: a randomized trial. Am J Med. 2015; 128 (12): 1351-1361.

  20. Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky DE et al. Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension. 2011; 58 (5): 804-810.

  21. Zeber JE, Manias E, Williams AF, Hutchins D, Udezi WA, Roberts CS et al. A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest group. Value Health. 2013; 16 (5): 891-900.

  22. Seabury SA, Gupta CN, Philipson TJ, Henkhaus LE; PhRMA Medication Adherence Advisory Council. Understanding and overcoming barriers to medication adherence: a review of research priorities. J Manag Care Pharm. 2014; 20 (8): 775-783.

  23. Ingaramo RA, Vita N, Bendersky M, Arnolt M, Bellido C, Piskorz D. Estudio Nacional Sobre Adherencia al Tratamiento (ENSAT). Rev Fed Arg Cardiol. 2005; 34: 104-111.

  24. Granados G, Roales J. Creencias relacionadas con la hipertensión y adherencia a los diferentes componentes del tratamiento. Intern Jour Psych Psychol Ther. 2007; 7 (3): 393-403.

  25. Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy: review paper. J Clin Hypertens (Greenwich). 2009; 11 (7): 376-382.

  26. Mayberry L, Osborne C. Empirical validation of the information-motivation-behavioral skills model of diabetes medication adherence: a framework for intervention. Diabetes Care. 2014; 37 (5): 1246-1253.

  27. Pozo MC, Alonso-Morillejo E, Hernández PS. Diseńo de
una intervención psicosocial dirigida al incremento de la adherencia al tratamiento en pacientes crónicos. In: Blanco A, Rodríguez-Marín J, eds. Intervención psicosocial. Madrid: Pearson Prentice Hall; 2007. pp. 75-101.

  28. Sieben A, van Onzenoort HA, van Laarhoven KJ, Bredie SJ. A multifaceted nurse- and web-based intervention for improving adherence to treatment in patients with cardiovascular disease: rationale and design of the MIRROR trial. JMIR Res Protoc. 2016; 5 (3): e187.

  29. Hedegaard U, Kjeldsen LJ, Pottegĺrd A, Henriksen JE, Lambrechtsen J, Hangaard J et al. Improving medication adherence in patients with hypertension: a randomized trial. Am J Med. 2015; 128 (12): 1351-1361.

  30. Krueger K, Botermann L, Schorr SG, Griese-Mammen N, Laufs U, Schulz M. Age-related medication adherence in patients with chronic heart failure: a systematic literature review. Int J Cardiol. 2015; 184: 728-735.

  31. Han E, Suh DC, Lee SM, Jang S. The impact of medication adherence on health outcomes for chronic metabolic diseases: A retrospective cohort study. Res Social Adm Pharm. 2014; 10 (6): e87-98.

  32. Saleem R, Hassali M, Shafie A, Atif M. Drug attitude and adherence: a qualitative insight of patients with hypertension. J Young Pharm. 2012, 4 (2): 101-107.

  33. Ajjar I, Kotchen T. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; 290 (2): 199-206.

  34. Arévalo AM, López GM, López SD, Martínez RF. Adherencia a la terapéutica farmacológica en pacientes con hipertensión arterial. Revista Médica HJCA. 2016; 8 (1): 8-13.

  35. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions. Arch Intern Med. 2007; 167 (6): 540-550.

  36. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical guideline [CG76]. National Institute for Health and Clinical Excellence; 2009.

  37. Hansen RA, Voils CI, Farley JF, Powers BJ, Sanders LL, Sleath B et al. Prescriber continuity and medication adherence for complex patients. Ann Pharmacother. 2015; 49 (3): 293-302.

  38. Ferdinand KC, Senatore FF, Clayton-Jeter H, Cryer DR, Lewin JC, Nasser SA et al. Improving medication adherence in cardiometabolic disease, practical and regulatory implications. J Am Coll Cardiol. 2017; 69 (4): 437-451.




2020     |     www.medigraphic.com